Mammogen Secures Up to $30 Million Series A Financing Backed by Leading U.S. Public Retirement System to Advance Blood-...
NEWPORT BEACH, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Mammogen, a female-led predictive health company developing RNA-powered molecular diagnostics for women’s health, today announced an up to $30 million institutional Series A equity financing led by …